F B Hagemeister - JoVE Visualize

Showing results (21-30 of 124) with videos related to

Pageof 13

Sort By:

Cancer|July 1, 1990

Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisoneS S Givens, L M Fuller, F B Hagemeister, et al.

Radiology|September 1, 1987

Regression of mediastinal Hodgkin disease after therapy: evaluation of time intervalL B North, L M Fuller, J A Sullivan-Halley, et al.

Blood|February 15, 1992

Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphomaF Cabanillas, W S Velasquez, F B Hagemeister, et al.

Clinical Lymphoma, Myeloma & Leukemia|October 12, 2025

Curability Potential of Low-Grade Follicular LymphomaF Cabanillas, J G Conde, T Gutierrez, et al.

Annals of Internal Medicine|November 1, 1994

Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphomaJ F Seymour, R F Gagel, F B Hagemeister, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992

NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysisF B Hagemeister, L Fuller, P McLaughlin, et al.

Leukemia & Lymphoma|June 28, 2001

Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphomaA Younes, M Cristofanilli, P McLaughlin, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987

Results of MIME salvage regimen for recurrent or refractory lymphomaF Cabanillas, F B Hagemeister, P McLaughlin, et al.

International Journal of Radiation Oncology, Biology, Physics|April 1, 1988

The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary resultsL M Fuller, F B Hagemeister, L B North, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987

MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's diseaseF B Hagemeister, N Tannir, P McLaughlin, et al.

Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:

Pageof 13

Cancer|July 1, 1990

Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisoneS S Givens, L M Fuller, F B Hagemeister, et al.

Radiology|September 1, 1987

Regression of mediastinal Hodgkin disease after therapy: evaluation of time intervalL B North, L M Fuller, J A Sullivan-Halley, et al.

Blood|February 15, 1992

Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphomaF Cabanillas, W S Velasquez, F B Hagemeister, et al.

Clinical Lymphoma, Myeloma & Leukemia|October 12, 2025

Curability Potential of Low-Grade Follicular LymphomaF Cabanillas, J G Conde, T Gutierrez, et al.

Annals of Internal Medicine|November 1, 1994

Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphomaJ F Seymour, R F Gagel, F B Hagemeister, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992

NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysisF B Hagemeister, L Fuller, P McLaughlin, et al.

Leukemia & Lymphoma|June 28, 2001

Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphomaA Younes, M Cristofanilli, P McLaughlin, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987

Results of MIME salvage regimen for recurrent or refractory lymphomaF Cabanillas, F B Hagemeister, P McLaughlin, et al.

International Journal of Radiation Oncology, Biology, Physics|April 1, 1988

The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary resultsL M Fuller, F B Hagemeister, L B North, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987

MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's diseaseF B Hagemeister, N Tannir, P McLaughlin, et al.

Pageof 13